Contrasting nuclear dynamics of the caspase-activated DNase (CAD) in dividing and apoptotic cells by Lechardeur, Delphine et al.
T
H
E
J
O
U
R
N
A
L
O
F
C
E
L
L
B
I
O
L
O
G
Y
 
©
 
 The Rockefeller University Press $8.00
The Journal of Cell Biology, Vol. 167, No. 5, December 6, 2004 851–862
http://www.jcb.org/cgi/doi/10.1083/jcb.200404105
 
JCB: ARTICLE
 
JCB 851
 
Contrasting nuclear dynamics of the caspase-
activated DNase (CAD) in dividing and 
apoptotic cells
 
Delphine Lechardeur,
 
1
 
 Ming Xu,
 
2
 
 and Gergely L. Lukacs
 
1
 
1
 
Program in Cell and Lung Biology, Hospital for Sick Children Research Institute and Department of Laboratory Medicine and Pathobiology, University of Toronto, Toronto, 
Ontario M5G 1X8, Canada
 
2
 
Department of Cell Biology, Neurobiology, and Anatomy, University of Cincinnati College of Medicine, Cincinnati, OH 45267
 
lthough compelling evidence supports the central
role of caspase-activated DNase (CAD) in oligo-
nucleosomal DNA fragmentation in apoptotic
nuclei, the regulation of CAD activity remains elusive in
vivo
 
.
 
 We used ﬂuorescence photobleaching and bio-
chemical techniques to investigate the molecular dynamics
of CAD. The CAD-GFP fusion protein complexed with its
inhibitor (ICAD) was as mobile as nuclear GFP in the
nucleosol of dividing cells. Upon induction of caspase-3–
dependent apoptosis, activated CAD underwent progressive
immobilization, paralleled by its attenuated extractability
A
 
from the nucleus. CAD immobilization was mediated by
its NH
 
2
 
 terminus independently of its DNA-binding activ-
ity and correlated with its association to the interchromo-
somal space. Preventing the nuclear attachment of CAD
provoked its extracellular release from apoptotic cells.
We propose a novel paradigm for the regulation of CAD
in the nucleus, involving unrestricted accessibility of chro-
mosomal DNA at the initial phase of apoptosis, followed
by its nuclear immobilization that may prevent the release
of the active nuclease into the extracellular environment.
 
Introduction
 
Apoptosis, or programmed cell death, allows the elimination
of unwanted cells during normal development and tissue ho-
meostasis without affecting the viability of adjacent cells. At
the molecular level, apoptosis comprises a cascade of pro-
teolytic events mediated by a family of cysteine-aspartate
proteases, the caspases, involved in both the signaling and the
execution phase of cell death (Nicholson, 1999). Apoptotic
cells undergo preprogrammed morphological changes, reflected
by cell and nuclear shrinkage, chromatin condensation, and
apoptotic body formation, ultimately engulfed by scavenger
cells (Hanayama et al., 2002). One of the biochemical hallmarks
of apoptosis is the cleavage of nuclear DNA into oligonucleo-
some-sized fragments, or DNA fragmentation, a mechanism
proposed to be essential for preventing autoimmune diseases
and horizontal gene transfer (Herrmann et al., 1998; Zhang
and Xu, 2002).
Caspase-activated DNase (CAD) is activated by the cas-
pase-3–dependent cleavage of the DNA fragmentation factor
(DFF), which contains two subunits, the CAD and the inhib-
itor of CAD (ICAD). CAD and ICAD have an NH
 
2
 
-termi-
nal homologous domain, the cell-inducing DFF45-like effector
(CIDE) domain, responsible for the heterodimerization of
ICAD and CAD (CAD/ICAD) (Aravind et al., 1999). Besides
inhibiting CAD activity, ICAD is also essential for the folding
of CAD by functioning as a chaperone (Enari et al., 1998; Sa-
kahira et al., 1999, 2000). CAD appears to be the most impor-
tant apoptotic nuclease because chromatin condensation and
DNA fragmentation were substantially delayed in ICAD
 
 
 
/
 
 
 
mouse embryonic fibroblasts (MEFs) lacking functional CAD,
in cells expressing caspase-resistant ICAD, as well as in
CAD
 
 
 
/
 
 
 
 thymocytes (Zhang et al., 1998; Hanayama et al.,
2002; Nagata et al., 2003).
We and others have demonstrated that two NLSs, identi-
fied at the COOH terminus of both CAD and ICAD, are neces-
sary and sufficient for the nuclear targeting of CAD/ICAD
(Samejima and Earnshaw, 1998; Lechardeur et al., 2000;
Scholz et al., 2002). After caspase-3–mediated cleavage of
ICAD, activated CAD is released and generates double-
stranded breaks in the chromatin (Halenbeck et al., 1998; Saka-
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hira et al., 1998; Liu et al., 1999). In addition to CAD, endonu-
clease G and the apoptotic inducing factor are implicated in the
cell-autonomous chromosomal DNA degradation (Penninger
and Kroemer, 2003). However, complete cleavage of chromo-
somal DNA requires the activity of the lysosomal DNase II,
after the phagocytic engulfment of apoptotic bodies (Nagata
et al., 2003).
Both homo- and heteromeric protein–protein interactions
have been invoked in the regulation of CAD activity. In vitro
biochemical studies suggested that histone H1, as well as high
mobility group (HMG) 1/2 proteins and topoisomerase II interact
with CAD and may tether the CAD/ICAD complex to the chro-
matin (Zhang and Xu, 2002). These interactions were proposed
to regulate the nuclease activity of CAD by influencing the DNA
conformation and/or acting as allosteric activators (Liu et al.,
1998, 1999; Toh et al., 1998; Zhang and Xu, 2002). Because his-
tone H1 and HMG 1/2 bind to the linker region of the relatively
immobile chromatin (Misteli et al., 2000; Kimura and Cook,
2001), it is anticipated that complex formation of CAD with
these nuclear proteins would limit the substrate accessibility of
the nuclease both in space and time. Other studies suggested that
activated CAD forms large homo-oligomeric complexes (
 
 
 
1
MD), which could restrict its diffusion (Liu et al., 1999; Meiss et
al., 2001; Widlak and Garrard, 2001; Zhou et al., 2001).
To resolve these contrasting observations and establish
the molecular dynamics of CAD in living cells, we used a com-
bination of morphological, biochemical, and biophysical tech-
niques. Our results indicate that the mobility of the CAD/ICAD
complex is similar to freely moving nuclear proteins in divid-
ing cells, implying that there are no or only transient interac-
tions with immobile nuclear constituents. Although activated
CAD displays virtually free diffusion at the initial stage of
apoptosis, movements of CAD become gradually restricted
during the progression of apoptosis. This appears to be a conse-
quence of CAD association with the nuclear matrix. We pro-
pose that immobilization of CAD may represent a protective
mechanism against the release of the activated DNase into the
extracellular space,
 
Results
 
CAD becomes resistant to detergent 
extraction in apoptotic nuclei
 
We used epitope-tagged CAD/ICAD to investigate whether the
CAD/ICAD heterodimer binds to nuclear constituents by immu-
nostaining. Both HA-tagged CAD and ICAD-myc transiently ex-
pressed in HeLa cells. Both proteins were confined to the nuclei
(Fig. 1 A, left, 
 
 
 
perm; Lechardeur et al., 2000). Permeabilization
of the cells by the nonionic detergent Triton X-100 before fixa-
tion provoked the complete loss of HA-CAD/ICAD-myc from
the nuclei of normal cells (Fig. 1 A, left, 
 
 
 
perm). EGFP harbor-
ing three tandem repeats of the NLS of the SV40-antigen (GFP-
NLS) was also depleted, validating the permeabilization proce-
dure (Fig. 1 B, left; 
 
 
 
perm). In contrast, association of core and
linker histones with the chromosomal DNA was retained in per-
meabilized cells (Fig. 1 C, left; 
 
 
 
perm). Collectively, these ob-
Figure 1. Extractability of CAD from normal and apoptotic HeLa cells. (A–C) Indirect immunofluorescence of (A) HA-CAD/ICAD-myc, (B) GFP-NLS, and
(C) histones in HeLa cells. The indicated proteins were immunostained in cells fixed with PFA before ( perm) or after ( perm) permeabilization in cytoskeletal
buffer containing 0.2% Triton X-100. DNA was stained with DAPI. Apoptosis was induced with STS for 2 h. Single optical sections were acquired with a
fluorescence microscope (DMI RE2; Leica) and OpenLab software. Bars, 10  m. (D) Nuclear retention of endogenous CAD. Lysates were prepared from
normal and apoptotic HeLa cells before (lane 1) or 5 min after (lane 3) permeabilization as in A–C. Extracellular release of CAD from the cells is shown in
lanes 2 and 4. Apoptosis was induced with STS for 2 h. Cell lysates and medium corresponding to the same number of cells was processed for Western
blot using an anti-CAD antibody. 
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servations suggest the CAD/ICAD complex can be released from
the nuclei similarly to soluble proteins such as GFP-NLS.
Staurosporine (STS), a nonspecific inhibitor of PKC and
an effective apoptosis-inducing agent, activates caspase-3 and
triggers the proteolysis of ICAD (Samuelsson et al., 2002).
A significant fraction of both endogenous and heterologous
ICAD was degraded after 2 h of STS treatment (Fig. 2 A; Le-
chardeur et al., 2000). As a corollary, substantial DNA frag-
mentation occurred, as indicated by the appearance of the oli-
gonucleosomal DNA ladder in apoptotic cells (Fig. 2 B).
STS-induced apoptosis delayed the release of HA-CAD from
permeabilized cells as compared with control (Fig. 1 A). Mean-
while, the extractability of neither GFP-NLS (Fig. 1 B, right
panels) nor the cleaved endogenous nor the exogenous ICAD
was altered (Fig. 1 A, right, 
 
 
 
perm and unpublished data).
Because anti-CAD antibodies have insufficient specificity
for immunostaining, extractability of endogenous CAD was
tested by Western blotting. Although CAD could not be detected
in the extracellular medium of nonpermeabilized cells (Fig. 1 D,
lanes 1 and 2), 90% of the cellular CAD content was released af-
ter permeabilization of nonapoptotic cells (Fig. 1 D, lanes 3 and
4). In contrast, apoptosis induction substantially decreased the
amount of CAD released into the extracellular medium: more
than 70% of the cellular CAD content remained associated with
the apoptotic cells after Triton X-100 treatment (Fig. 1 D, bottom,
lanes 3 and 4). The nuclear retention of CAD suggests that acti-
vated CAD has increased affinity to some of the immobile com-
ponent(s) of the apoptotic nucleus. To test this hypothesis and
compare the molecular dynamics of CAD in proliferating and ap-
optotic cells, we used fluorescence photobleaching techniques.
 
Characterization of CAD-GFP fusion 
protein
 
To characterize the diffusional mobility of CAD, an HA-CAD-
EGFP (CAD-GFP) fusion protein was constructed. Compelling
evidence indicates that CAD-GFP mimics the cellular behavior
of endogenous CAD. First, CAD-GFP is targeted into the nucleus
and was coprecipitated with ICAD-myc in normal cells (Fig. 2 C;
Fig. 2 E, left, 
 
 
 
perm). Second, the steady-state protein level of
CAD-GFP was substantially increased (5–8-fold) upon its coex-
pression with ICAD-myc (Fig. 2 D; lanes 1 and 2), suggesting
that the biosynthesis of CAD-GFP, similarly to HA-CAD and
CAD, requires the chaperone function of ICAD. Because most of
the endogenous ICAD is associated with endogenous CAD, the
folding of CAD-GFP is severely impaired in the absence of
ICAD. Third, rapid degradation of both endogenous and exoge-
nous ICAD was observed in STS-treated HeLa cells, regardless
of whether the CAD/ICAD heterodimer contained CAD-GFP or
Figure 2. Biogenesis and stability of CAD and
ICAD in dividing and apoptotic cells. (A) The
stability of endogenous ICAD and CAD in
HeLa cells during STS-induced apoptosis. Cel-
lular proteins (40  g) were separated by SDS-
PAGE and probed by immunoblotting with
anti-CAD and anti-ICAD antibodies. (B) Inter-
nucleosomal DNA fragmentation after 2.5 h
apoptosis (lane 3). The accumulation of 200-bp
nucleosomal DNA fragments is characteristic of
late stage of apoptosis. Soluble DNA frag-
ments were absent in control HeLa cells (lane 2).
1-kb DNA ladder; lane 1. (C and D) HeLa
cells were transiently transfected with the HA-
CAD-GFP and ICAD-myc vectors or carrier
DNA. (C) Cell lysates from normal (lane 2)
and STS treated HeLa cells (lane 3) were im-
munoprecipitated with an anti-GFP antibody.
Precipitates (top panel) and 10% of the lysates
(bottom panels) were immunoblotted. (D) The
expression and stability of ICAD-myc and
CAD-GFP were determined as described in A.
(E) Indirect immunofluorescence of HeLa cells
expressing CAD-GFP/ICAD-myc fixed before
( perm) or after ( perm) permeabilization as
in Fig. 1 A. (F) Number of cells retaining nu-
clear CAD-GFP and GFP-NLS under perme-
abilization. After in vivo permeabilization as
in A, cells were fixed and chromatin was
counter-stained with DAPI. Approximately 500
nuclei were scored for their fluorescence for each condition. The number
of cells expressing CAD-GFP was expressed as the percentage of nuclei
remaining fluorescent upon permeabilization of cells. (G) DNase activity
of CAD-GFP. Transiently expressed HA-CAD-GFP/ICAD myc was immu-
noisolated from HeLa cell lysate with an anti-HA antibody on protein
G–Sepharose. Purified HA-CAD-GFP/ICAD-myc complex was incubated
with plasmid DNA alone (lane 3,  casp) or in the presence of recombi-
nant caspase-3 (lane 4,   casp). Nontransfected cells were used as
control (lanes 5 and 6). 
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endogenous CAD (Fig. 2, A and D). STS induced 
 
 
 
50% degra-
dation of the endogenous ICAD and 
 
 
 
50% of ICAD-myc after 2
and 1.5 h incubation, respectively (Fig. 2, A and D), demonstrat-
ing that CAD-GFP chimera does not interfere with the caspase-
3–dependent proteolysis of ICAD. Fourth, permeabilization of
the cells by Triton X-100 triggered the complete release of CAD-
GFP from dividing, but not from apoptotic cells, similarly to that
observed for HA-CAD (Fig. 2, E and F). Fluorescent nuclei of
CAD-GFP/ICAD-myc– or GFP-NLS–expressing cells perme-
abilized as above were scored. Although CAD-GFP was released
from nearly all of the dividing cells, 90% of the apoptotic nuclei
retained CAD-GFP but not GFP-NLS (Fig. 2 F). Finally, purified
HA-CAD-GFP/ICAD-myc heterodimer from HeLa cells exhib-
ited nuclease activity after the proteolytic cleavage of ICAD by
caspase-3, suggesting that the fusion protein retained nucleolytic
activity (Fig. 2 G). Together, these data suggest that CAD-GFP is
an authentic surrogate of the native CAD.
 
The CAD/ICAD heterodimer is mobile in 
the nucleus of proliferating cells
 
To compare the dynamics of CAD-GFP/ICAD with freely
moving GFP and GFP-NLS in live cells, we measured their
one-dimensional diffusion coefficient and mobile fraction by
FRAP technique in HeLa cells. More than 80% of the initial
fluorescence of CAD-GFP as well as GFP-NLS was recovered
in 2–3 s, whereas complete recovery of GFP was attained in 
 
 
 
1 s
after the bleach (Fig. 3, A and B). CAD-GFP diffusional coef-
ficient (D
 
CAD-GFP
 
 
 
 
 
 1.34 
 
 
 
 0.20 
 
 
 
m
 
2
 
/s; 
 
n
 
 
 
 
 
 32, mean 
 
 
 
 SEM)
was comparable to that of GFP-NLS (D
 
GFP-NLS
 
 
 
 
 
 0.94 
 
 
 
 0.10
 
 
 
m
 
2
 
/s; 
 
n
 
 
 
 
 
 47), but was 6.6-fold slower than GFP (D
 
GFP
 
 
 
 
 
8.95 
 
 
 
 0.95 
 
 
 
m
 
2
 
/s; 
 
n
 
 
 
 
 
 36) (Fig. 3 C). In comparison, the
diffusional coefficient of histone H1 (H1.1-GFP,D
 
H1.1GFP
 
 
 
 
 
0.019 
 
 
 
 0.003 
 
 
 
m
 
2
 
/s; 
 
n
 
 
 
 
 
 20) was 
 
 
 
70-fold slower (Fig. 3, A
and C). The slow mobility of H1.1-GFP confirms previously
published results (Misteli et al., 2000; Kimura and Cook, 2001).
To elucidate whether the entire nuclear pool of CAD-
GFP/ICAD is mobile, fluorescence loss induced by photo-
bleaching (FLIP) was performed. Repeated spot photobleach-
ing completely depleted the fluorescence of CAD-GFP and
GFP-NLS at comparable rates in the entire nucleus (Fig. 3, D
and E; Video 1, available at http://www.jcb.org/cgi/content/
full/jcb.200404105/DC1).
The possibility that high-affinity binding sites are satu-
rated by the heterologously expressed CAD/ICAD complex
Figure 3. Nuclear dynamics of CAD in dividing HeLa cells. (A) Pho-
tobleaching of nuclear CAD-GFP, GFP-NLS, GFP, and H1.1-GFP in tran-
siently transfected HeLa and MEF ICAD
 /  cells. FRAP was performed as
described in Materials and methods. Images show single x-y sections of
the nucleus and were obtained before (pre) and after the bleach at indi-
cated times. Although the laser intensity was sufficient to cause complete
loss of fluorescence in PFA fixed cells, partial recovery occurred during the
first scan due to the rapid lateral diffusion of the GFP chimeras. (B) Quan-
titative FRAP. Normalized fluorescence recovery was plotted as a function
of time. Negligible recovery occurs on PFA-fixed HeLa cells ( PFA). (C)
Diffusional coefficients of GFP and GFP chimeras in the nucleus of HeLa
cells. The recovery curves were fitted according to a one-dimensional diffu-
sion formula described in Materials and methods. Data are means  
SEM; n is indicated in brackets. (D) FLIP of CAD-GFP and GFP in HeLa
cells. A 2- m circle in the nucleus of HeLa cells expressing CAD-GFP or
GFP was bleached in every 10 s. The entire nucleus was imaged after
each bleach. Scans of the remaining fluorescence in the whole nucleus are
shown for CAD-GFP– and GFP-expressing cells for the indicated times
after the first bleach. Bar, 5  m. (E) Quantitative FLIP. The ratio of the average fluorescence intensity of the half nucleus opposite to the bleach spot relative
to the prebleach image was plotted at each time point. (F) Diffusional coefficients of CAD-GFP/ICAD in the nucleus of HeLa, BHK, MCF7, and MEF ICAD
 / 
cells. Diffusional coefficients were calculated as described in C. Data are means   SEM. 
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was tested in MEFs, derived from ICAD
 
 
 
/
 
 
 
 mouse, lacking en-
dogenous CAD/ICAD (Zhang et al., 1998). Quantitative FRAP
analysis showed that the CAD-GFP/ICAD has a comparable
diffusion constant (D
 
CAD-GFP
 
 
 
 
 
 2.6 
 
 
 
 0.50 
 
 
 
m
 
2
 
/s) in MEF
ICAD
 
 
 
/
 
 
 
 to that in BHK, HeLa, and MCF7 cells together with
an absence of detectable size of immobile pool (Fig. 3 F and un-
published data). Finally, short-term ATP depletion of HeLa
cells has only a marginal effect on the diffusional coefficient of
CAD-GFP (D
 
CAD-GFP
 
 
 
 
 
 0.60 
 
 
 
 0.03 
 
 
 
m
 
2
 
/s; 
 
n
 
 
 
 
 
 10) as well as
GFP-NLS (D
 
GFP-NLS
 
 
 
 
 
 0.62 
 
 
 
 0.04 
 
 
 
m
 
2
 
/s; 
 
n
 
 
 
 
 
 10), suggesting
that the rapid movement of the CAD/ICAD complex is inde-
pendent of metabolic energy. Although the possibility that
CAD/ICAD undergoes a transient association with nuclear sub-
strates cannot be precluded, the mobility measurements and the
permeabilization studies suggested that CAD/ICAD, similarly
to GFP-NLS, diffuses relatively freely in contrast to the slowly
moving histone H1 and chromatin in proliferating cells.
 
Immobilization of CAD in apoptotic nuclei
 
The nuclear retention of both HA-CAD and CAD-GFP in per-
meabilized apoptotic cells is consistent with the notion that the
diffusion of CAD became restricted during apoptosis (Fig. 1 A
and Fig. 2 E). To further characterize this process, FRAP mea-
surements were performed by spot photobleaching on HeLa
nuclei. After an initial lag period (1–1.5 h), the immobile frac-
tion of CAD-GFP progressively increased in the nucleus of a
single cell (Fig. 4, A and B). To verify that CAD immobiliza-
tion requires the activation of the apoptotic enzyme cascade,
the translocation of phosphatidylserine into the outer leaflet of
the plasma membrane was measured simultaneously with CAD
mobility on STS-treated cells. Remarkably, the immobilization
of CAD was observed only in those cells that displayed an-
nexin V staining and plasma membrane blebbing (Fig. 4, C and
D). To confirm this notion, the mobility of CAD was deter-
mined on a large number cells after induction of apoptosis, as
well as in cells deficient of functional caspase-3.
As illustrated by the time-lapse images of CAD-GFP re-
coveries (Fig. 5 A) and the statistical analysis, STS provoked a
modest immobilization of CAD during the first 2 h of apoptosis
(Fig. 5, B and C). Extending the incubation time to 3 h in-
creased the t
 
1/2
 
 by 
 
 
 
20 fold (t
 
1/2
 
 
 
 
 
 23 
 
 
 
 4.6 s; 
 
n
 
 
 
 
 
 18) relative
to the control (t
 
1/2
 
 
 
 
 
 1.0 
 
 
 
 0.05 s; 
 
n
 
 
 
 
 
 39) (Fig. 5 B). A frac-
tion of CAD (40 
 
 
 
 4.2%; n   20) became immobile between
2–3 h of apoptosis induction (Fig. 5 C). Extending the incuba-
tion up to 3 h immobilized  80% of CAD-GFP (Fig. 5 C).
Similar nuclear immobilization was observed in BHK and
MEF ICAD
 /  cells, as well as using the mouse CAD-GFP fu-
sion protein, suggesting that CAD immobilization is cell- and
species-independent (unpublished data). Inhibition of CAD dif-
fusion was not restricted to specific regions, but affected the
entire nucleus, as demonstrated by FLIP analysis (Video 1 and
Fig. S2, A and B; available at http://www.jcb.org/cgi/content/
full/jcb.200404105/DC1). In contrast, the diffusional mobility
of GFP-NLS was not altered in apoptotic cells, as shown by the
rapid fluorescence recovery rate and insignificant immobile
fraction of GFP-NLS after 3 h of STS treatment (Fig. 5, B and
C; Fig. S2). The lack of GFP-NLS immobilization cannot be
attributed to the slower onset of nuclear apoptosis because a
negligible effect on the mobility of GFP-NLS was observed in
cells coexpressing HA-CAD/ICAD or using the DNase-defi-
cient CADH242N-GFP fusion protein (unpublished data and
see following paragraph).
Figure 4. Immobilization of CAD in apoptotic nucleus. The mobility of
CAD-GFP was monitored by spot photobleaching in the nucleus of transiently
transfected HeLa cells exposed to STS for the indicated time. (A and B) FRAP
of a single nucleus at different times of apoptosis. (A) Single x-y optical sec-
tions of nucleus. The circles indicate the bleached area. Bar (A), 5  m. The
corresponding recovery curves are plotted in B. Note that after 2 h of apop-
tosis, recovery in the bleached areas is negligible (indicated by arrow-
heads). (C and D) Phosphatidylserine translocation and CAD-GFP mobility.
FRAP was performed as in A on cells incubated with Alexa 594–labeled
annexin V. Cells were visualized by differential interference contrast micros-
copy. The corresponding recovery curves are shown in D. Bar (C), 10  m.JCB • VOLUME 167 • NUMBER 5 • 2004 856
Several lines of evidence suggested that the immobiliza-
tion of CAD required caspase-3 activation: (1) treatment of the
cells with the pan-caspase inhibitor Z-VAD-fmk, or with the
caspase-3–specific inhibitor DEVD-CHO abolished the immo-
bilization of CAD upon STS treatment (Fig. 6 A); (2) the diffu-
sional mobility of CAD was preserved in STS-treated MCF7
cells that lack functional caspase-3 (Fig. 6 B, top; Fig. 6 C and
Video 1), but CAD-GFP was immobilized in MCF7 cells ex-
pressing functional caspase-3 (Fig. 6 B, bottom; Fig. 6 C); (3)
immobilization of activated CAD is not restricted to cells un-
dergoing STS-induced apoptosis: CAD was also immobilized
to comparable extent in HeLa cells subjected to UV irradiation
or CHX and TNF  treatment (Fig. S3, B, C, F, and G; available
at http://www.jcb.org/cgi/content/full/jcb.200404105/DC1).
Both inducers provoked the degradation of ICAD (Fig. S3, A
and E) and their effects on CAD immobilization were pre-
vented in the presence of the caspase-3 inhibitor DEVD-CHO
(Fig. S3, D and H), implying that CAD activation occurred via
the caspase-3–dependent pathway. Collectively, these results
suggest that immobilization of CAD-GFP is a common feature
of nuclei undergoing caspase-3–dependent apoptosis regardless
of the upstream signaling mechanism.
The mechanism of CAD immobilization in 
apoptotic nuclei
Four possible mechanisms were considered to account for
CAD immobilization in apoptotic nuclei. The first possibility
that increased viscosity of the nucleosol impedes the diffusion
of CAD-GFP could be ruled out based on the observation that
neither the immobile fraction nor the recovery kinetics of
GFP-NLS and GFP were significantly altered in apoptotic
HeLa cells (Fig. 5, B and C; Fig. S2). The second scenario that
Figure 5. The diffusional mobility of CAD-GFP and GFP-NLS in HeLa cells
undergoing apoptosis. FRAP experiments and confocal imaging were con-
ducted as described in Fig. 3. (A) Qualitative FRAP during apoptosis. Rep-
resentative nuclei of different cells, expressing CAD-GFP, were imaged
before and during the recovery after photobleaching the boxed area.
Near-complete immobilization of CAD-GFP was observed after 3 h of STS
treatment. Bar, 5  m. (B) Half-time of fluorescence recoveries and (C) immo-
bile fractions of CAD-GFP and GFP-NLS after STS exposure for the indicated
duration. Half-time of recoveries were calculated from normalized recovery
curves of 30–40 individual cells for each time interval. The mobile fraction
was calculated as the percentage of corrected total fluorescence intensity
reached during the recovery phase (see Materials and methods).
Figure 6. The immobilization of CAD in the apoptotic nucleus is caspase-3
dependent. (A) Effect of caspase inhibitors on CAD-GFP diffusional mobility.
HeLa cells were exposed to STS for 3 h in the presence of DEVD-CHO
(20  M) or ZVAD-fmk (50  M). Immobile fraction was determined by
FRAP as described in Fig. 5. (B and C) CAD-GFP is immobilized only in
exogenous caspase-3–expressing MCF7 cells. (B) x-y optical sections of
MCF7 cells, cotransfected with CAD-GFP, ICAD-myc, and procaspase-3.
Cells were incubated for 3.5 h with STS before the caspase-3 substrate
Red-DEVD-fmk was added to the medium to identify cells containing only
CAD-GFP ( casp3) or both CAD-GFP and active caspase-3 ( casp3).
CAD-GFP mobility was measured by FLIP as described in Fig. 3 D. Bar,
10  M. (C) Results from B were plotted as in Fig. 3 D. Control represents
a nontreated MCF7 cell.NUCLEAR DYNAMICS OF CAD • LECHARDEUR ET AL. 857
apoptosis facilitates the complex formation of CAD-GFP with
chromatin could be also discounted because neither CAD-GFP
nor CAD-HA colocalized with the condensed chromatin of ap-
optotic cells (Fig. 1, A and C; Fig. 2 E). The subnuclear distri-
bution of CAD was distinct from endogenous histones (Fig. 1,
compare A, E, and C). In addition, complete digestion of the
chromosomal DNA by DNase did not cause the liberation of
CAD from apoptotic nuclei (see following paragraph). Finally,
replacement of His242 by Ala, an amino acid residue critical
for DNA binding of CAD (Meiss et al., 2001), failed to pre-
vent the immobilization of CADH242A-GFP (Fig. S4, avail-
able at http://www.jcb.org/cgi/content/full/jcb.200404105/
DC1), confirming that direct DNA binding of the nuclease is
not required.
As a third hypothesis, pronounced homo-oligomeriza-
tion of CAD as reported with the recombinant DNase previ-
ously (Liu et al., 1999; Meiss et al., 2001; Widlak and Gar-
rard, 2001; Zhou et al., 2001) into a high molecular weight
complex was also ruled out because CAD oligomers were not
detected by size-exclusion chromatography of apoptotic cell
extracts (unpublished data).
Finally, the hypothesis that CAD binds to the chromatin-
depleted subnuclear compartment, also called interchromatin
space or nuclear matrix, was tested. Nuclear matrix preparation
was obtained by the combination of successive detergent extrac-
tion, DNase digestion, and high salt washes of HeLa cells as de-
scribed previously (Nickerson et al., 1997). Although CAD was
largely depleted from the nuclear matrix preparation of nonapop-
totic cells, a significant fraction of CAD-GFP remained associ-
ated with nonchromatin proteins of apoptotic cells according to
immunoblot analysis (Fig. 7 A). The association of HA-CAD as
well as CAD-GFP with nuclear interchromatin structures could
be confirmed at the morphological level by fluorescence mi-
croscopy in apoptotic cells (Fig. 7, B and C), but not in control
cells. CAD remained nuclear upon the complete digestion of the
chromosomal DNA by DNase, verified by immunostaining of
DAPI-negative nuclei (Fig. 7, B and C). In contrast, nuclear ma-
trix preparations failed to retain GFP-NLS, visualized either by
fluorescence microscopy or by immunoblotting (unpublished
data). These observations are consistent with the notion that
CAD, but not the heterodimeric CAD/ICAD, preferentially
binds to the nuclear matrix of apoptotic cells.
Figure 7. Association of CAD with the nuclear matrix in apoptotic HeLa cells. (A) Biochemical isolation of nuclear matrix from cells expressing the CAD-
GFP/ICAD-myc complex. Apoptosis was induced with STS for 2 h. HeLa cells were biochemically fractionated and the CAD-GFP content of each fraction
was visualized by anti-GFP immunoblotting. Wcl, whole-cell lysate (lane 1); CSK, extraction with the cytoskeletal buffer (lane 2); DNaseI digestion (lane 3);
NaCl, high salt extraction (lane 4); and nuclear matrix proteins (lane 5). (B and C) In situ isolation of the nuclear matrix was performed as in A on HeLa
cells grown on glass coverslips. CAD-HA and chromatin was visualized by indirect immunostaining and with DAPI, respectively. Single x-y optical sections
are shown. (D) Colocalization of CAD-GFP and CAD-HA with NuMA. Apoptosis was induced with STS for 2 h. HeLa cells were immunostained with
anti-HA and anti-NuMa antibodies. (E) Colocalization of CAD-HA with NuMA. Immunostaining was performed as in D. Inset shows a magnification of the
images captured with a fluorescence microscope (DMI RE2; Leica), deconvolved, and analyzed using OpenLab software (Improvision). Single images
were selected for presentation. Bars, 10  m.JCB • VOLUME 167 • NUMBER 5 • 2004 858
To confirm our hypothesis that CAD is tethered to the nu-
clear matrix, coimmunostaining of CAD and nuclear mitotic ap-
paratus protein (NuMA), a component of the nuclear matrix (Fey
et al., 1991), was performed. A significant overlap in the nu-
clear localization of NuMA and CAD-GFP, as well as CAD-
HA, could be demonstrated by deconvolution fluorescence mi-
croscopy (Fig. 7, D and E; inset). Although these experiments
are unable to distinguish between direct and indirect binding of
CAD to the nuclear matrix, the results are consistent with the in
vivo FRAP measurements, indicating that activated CAD asso-
ciates with virtually immobile component(s) of apoptotic nuclei.
The NH2 terminus is required for nuclear 
immobilization of CAD
To elucidate the signal responsible for CAD association with the
nuclear matrix, progressive COOH- and NH2-terminal trunca-
tions of CAD were generated and fused in frame to EGFP (Fig. 8
A), and the mobility of the chimeras was measured. Truncated
variants of human CAD were designed based on sequence align-
ments of the human, mouse, chicken, and Drosophila CAD, re-
specting putative domain boundaries (Mukae et al., 2000) (Fig. 8
A). Western blot analysis verified the expected molecular mass
of the truncated CAD-GFP fusion proteins (Fig. 8 B). The nu-
clear mobility of truncated CAD was assayed in proliferating and
apoptotic HeLa cells. Four of the nine fusion proteins that were
immobilized in STS-treated HeLa cells contained amino acid
residues between 84 and 152 of CAD (CAD[1–152], [1–278],
[84–152], and [84–203]) (Fig. 8, A and C). In contrast, fusion
proteins incorporating peptide fragments of the COOH terminus
of CAD ([152–203], [203–278], [278–338], and [203–338]) or
the CIDE-N domain remained as mobile as GFP-NLS in apop-
totic cells (Fig. 8 A and unpublished data). The partial immobili-
zation of CAD[84–152] and CAD[84–203] was potentiated in
the presence of the CIDE-N domain because both CAD[1–152]
and CAD[1–278] were immobile in apoptotic nuclei (Fig. 8 C).
These results suggest that the NH2-terminal 152 amino acid resi-
dues are necessary for the immobilization of CAD.
The possible role of CAD immobilization 
in apoptotic cells
It is well documented that the integrities of the plasma and nu-
clear membranes are compromised during the late stages of
apoptosis (Faleiro and Lazebnik, 2000; Tzung et al., 2001). We
hypothesized that nuclear immobilization of the DNase prevents
its extracellular release. To test this assumption, we measured
the accumulation of CAD in the extracellular compartment un-
der conditions that interfered with its nuclear immobilization.
To prevent the immobilization of CAD, we took advan-
tage of our previous observation demonstrating that deletion of
the NLS in both CAD and ICAD caused the relocation of the
CAD- NLS/ICAD- NLS complex into the cytoplasm and
prevented nuclear uptake of CAD- NLS (Lechardeur et al.,
2000). Importantly, neither the dimerization nor the activation
kinetics of CAD was altered by deleting the two NLSs (unpub-
lished data). The extracellular liberation of HA-CAD from ap-
optotic HeLa cells expressing either CAD/ICAD or CAD-
 NLS/ICAD- NLS was determined by immunoblotting after
the immunoprecipitation of the extracellular CAD with anti-
HA antibody (Fig. 9). A significant fraction of CAD- NLS,
but not CAD, leaked into the medium from HeLa cells under-
going STS-induced apoptosis (Fig. 9, lanes 3 and 6). The ab-
sence of myc-tagged ICAD in the immunoprecipitates confirmed
that the proteolysis of ICAD-myc preceded the extracellular
egress of CAD (Fig. 9, bottom). Thus, nuclear entrapment of
CAD may have a critical role in preventing the extracellular re-
lease of the active DNase from apoptotic cells.
Figure 8. Localization of the nuclear matrix
targeting motif in CAD. (A) Schematic pictures
of deletion mutants of CAD fused to the NH2
terminus of EGFP. All constructs were freely
mobile in nonapoptotic cells. The relative
mobilities of the truncated CAD in STS-treated
cells are indicated by the size of the immobile
pool on the right, representing at least 10 in-
dependent measurements for each construct.
No or negligible effect,  ; partial immobiliza-
tion,   ; and complete immobilization,   .
(B) Mutant CAD-GFP fusion proteins were tran-
siently expressed in HeLa cells. The apparent
molecular mass of fusion proteins was as-
sessed by immunoblotting using an anti-GFP
antibody. (C) FRAP studies of selected CAD-
GFP fusion proteins. The mobility of the indi-
cated fusion proteins was determined with
FRAP as described in Fig. 3, before and after
STS (2 h) treatment. Representative categories
of the CAD chimera in apoptotic cells are
demonstrated. CIDE-GFP, marginal inhibition
of mobility (left); CAD[84–152]-GFP, partial
immobilization (middle); and CAD[1–152],
complete immobilization (right).NUCLEAR DYNAMICS OF CAD • LECHARDEUR ET AL. 859
Discussion
The experiments presented in this paper were designed to deter-
mine the molecular dynamics of CAD in living cells, critical for
our understanding of the regulation of the most important apop-
totic nuclease. In the nucleus of nonapoptotic cells, the CAD/
ICAD heterodimer was found to be as mobile as the nuclear tar-
geted EGFP, an archetype of freely diffusing proteins (Houts-
muller et al., 1999; Kruhlak et al., 2000). The fast diffusional
movements of CAD/ICAD were preserved after the acute ATP
depletion of HeLa cells, as well as in MEF ICAD
 /  cells, defi-
cient of the endogenous CAD/ICAD complex (Zhang et al.,
1999). These observations, together with the lack of discernible
immobile pool of CAD/ICAD, imply that the cellular dynamics
of the heterodimer could be ascribed as passive diffusion. Free
diffusion could optimize the probability of activation of CAD/
ICAD by providing an efficient scanning mechanism for cas-
pase-3 in the nuclear space, as reported for several other nu-
clear proteins (Pederson, 2001; Carmo-Fonseca et al., 2002).
Free diffusion would also ensure efficient catalytic binding of
CAD to the immobile chromatin during the initial phase of
apoptosis. The high mobility of the heterodimer is at variance
with previous suggestions, invoking high-affinity interactions
of CAD/ICAD with slowly moving or relatively immobile
(e.g., histone-H1 and chromatin) nuclear constituents (Liu et
al., 1998, 1999; Toh et al., 1998; Durrieu et al., 2000; Zhang
and Xu, 2002). More surprisingly, the molecular dynamics of
CAD undergo dramatic changes upon apoptosis. Data obtained
by both biochemical and biophysical techniques indicated that
the diffusional mobility of CAD is impeded in apoptotic nuclei.
In contrast, the diffusion of GFP-NLS and other nuclear pro-
teins, such as HMG N1, N2, and the transcription factor NF1,
were preserved (Stenoien et al., 2000; Scaffidi et al., 2002). The
activation of caspase-3 seems to be necessary for the immobili-
zation of CAD. Whether ICAD cleavage by caspase-3 is suffi-
cient or the modifications of other nuclear constituents are also
required for CAD immobilization remains to be determined.
Biochemical fractionation and immunocolocalization stud-
ies with NuMA suggested that CAD associates with the non-
chromatin subnuclear compartment, defined as the nuclear ma-
trix in apoptotic cells (Fey et al., 1991; Nickerson et al., 1997).
This conclusion is consistent with the observation that the nu-
clear retention of CAD was compromised in the absence of
oxovanadium-modified ribonucleosides (unpublished data), a
competitive ribonucleosidase inhibitor that is an efficient stabi-
lizer of the nuclear matrix (Stenoien et al., 2001).
The nuclear matrix is proposed to consist of the nuclear
envelope and a meshwork of nonchromatin nuclear proteins
(Nickerson, 2001). The subnuclear compartment is involved in
multiple nuclear functions such as chromatin dynamic organi-
zation and metabolism, RNA processing and regulation, or ste-
roid hormone action (Nickerson, 2001; Heng et al., 2004).
Modulation of protein partitioning between the nuclear matrix,
in an immobilized nonfunctional state, and the nucleoplasm, in
a mobile functional state, may constitute a fundamental regula-
tory mechanism. Short stretches of amino acids as well as large
segments of polypeptides can serve as nuclear matrix targeting
signals (NMTS) (Nickerson, 2001). Because no consensus
NMTS could be identified in CAD, deletional mutagenesis was
used to show that the NMTS encompasses aa [84–152] of
CAD, connecting the regulatory CIDE domain and the COOH-
terminal catalytic domain.
Dissociation of the heterodimer, by itself, seems likely to
be insufficient for targeting CAD to the nuclear matrix consid-
ering the following observations. Immunoblot analysis showed
that at least 50% of ICAD was degraded during the first 1.5 h
of apoptosis, expressing the CAD-HA/ICAD-myc or the CAD-
GFP/ICAD-myc complex (Fig. 2, B and E). In contrast, 50% of
the CAD-GFP became immobile only after 3 h of STS expo-
sure (Fig. 5 C). The degradation of ICAD presumably is com-
pleted shortly after its initiation at the single-cell level, similar
to that described for various caspase-3 substrates using the
FRET technique (Takemoto et al., 2003). The extensive DNA
ladder formation in STS-treated HeLa cells also supports the
notion that DNA fragmentation appears to take place before the
immobilization of CAD (Fig. 2 C). Considering the degrada-
tion kinetics of ICAD are faster than the immobilization of
CAD, it is conceivable that besides the dissociation of the
CAD/ICAD heterodimer, conformational and/or compositional
changes of binding partners are also required for nuclear en-
trapment of CAD.
If CAD diffusion is a prerequisite for its catalytic activity
on internucleosomal chromosomal regions of the virtually immo-
bile chromatin, our results suggest that CAD activity is limited to
a relatively short period of time. Thus, CAD would primarily be
responsible for the cleavage of the most susceptible A/T reach,
matrix attachment regions of chromatin and the induction of ge-
Figure 9. Interfering with nuclear entrapment of CAD facilitates its extra-
cellular release from apoptotic cells. (A) HeLa cells, transiently expressing
the mouse HA-CAD/ICAD-myc or the HA-CAD NLS/ICAD NLS-myc
complex were exposed to STS for 2.5 h in serum-free medium. CAD was
immunoprecipitated from both the medium (med) and the cell lysate (cell)
with anti-HA antibody. The precipitates and the cell lysates (lys) were
probed with anti-CAD and anti-myc antibodies to visualize exogenous
CAD and ICAD. (B) As a control, HeLa cells were transfected with the
HA-CAD NLS/ICAD NLS-myc and were incubated overnight in serum-
free medium. CAD was then immunoprecipitated from the medium and
probed with the indicated antibodies.JCB • VOLUME 167 • NUMBER 5 • 2004 860
nomic DNA condensation by destabilizing the chromatin struc-
ture, rather than for complete nucleosomal fragmentation.
Recent evidence suggests that nucleosomal fragmentation
by CAD is indeed not an absolute requirement for the elimina-
tion of apoptotic nuclei. Kawane et al. (2003) demonstrated
that phagocytosis plays an important role in the degradation
process of apoptotic bodies derived from CAD
 /  thymocytes
(see also Nagata et al., 2003). Although most of the apoptotic
cells are cleared by phagocytosis before losing membrane in-
tegrity, apoptotic bodies may escape their degradation and thus
provoke an immune response. Supporting this notion, imped-
ing nuclear apoptosis, as well as the degradation of apoptotic
nuclei, provokes the activation of innate immunity in DNase
II
 / CAD
 /  mice (Nagata et al., 2003).
The accumulation of nuclear proteins (e.g., core histones)
has been demonstrated not only in the cytosol, but also in the
extracellular compartment as well when the phagocytic capac-
ity of the organism is saturated by the number of apoptotic
lymphocytes (Gabler et al., 2003). This process leads to the
production of auto-antibodies against dsDNA and/or histones
in diseases such as the autoimmune lymphoproliferative syn-
drome (Chun et al., 2002) and lupus (Dieker et al., 2002).
These observations suggest that the nuclear–cytoplasmic bar-
rier can be compromised in apoptotic cells (Faleiro and Lazeb-
nik, 2000) and that specific mechanisms are in place to retain
potentially harmful proteins in those cells that undergo pro-
grammed cell death. Recent observations showed that the pro-
inflammatory transcription factor HMG B1 follows this para-
digm. Although HMG B1 is bound loosely to chromatin in
intact cells, it becomes tightly tethered to the condensed chro-
matin (Scaffidi et al., 2002). As a consequence, the extracellu-
lar release of HMG B1 is limited from apoptotic bodies, mini-
mizing a systemic immune response (Bianchi and Manfredi,
2004). Finally, Brinkmann et al. (2004) have recently shown that
activated neutrophils release proteins and chromatin fragments,
forming an extracellular mesh called the neutrophil extracellu-
lar trap (NET), which has a bactericidal effect. This structure
seems to be essential in the inflammatory response. The NET
has been shown to be disintegrated by exogenous DNaseI. Re-
lease of the active DNase by apoptotic cells in the extracellular
compartment could consequently compromise the integrity and
bactericidal activity of the NET. In conclusion, we propose that
retention of activated CAD in apoptotic nuclei may represent a
safeguard against the accumulation of active DNase in the ex-
tracellular compartment.
Materials and methods
Plasmid construction
The cDNA, encoding the human and mouse CAD, were provided by Dr. R.
Halenbeck (Chiron Corp., Emeryville, CA) and Dr. S. Nagata (Osaka Uni-
versity Medical School, Osaka, Japan), respectively. The cDNA of human
ICAD was cloned as described previously (Lechardeur et al., 2000). The
expression plasmid encoding the HA-CAD-EGFP fusion protein (CAD-GFP)
was constructed by inserting the coding region of the HA-CAD into pEGFP-
N1 plasmid (BD Biosciences). Other epitope-tagged CAD and ICAD were
obtained as described previously (Lechardeur et al., 2000). Nuclear-tar-
geted EGFP (GFP-NLS) was derived from pECFP-NUC (BD Biosciences).
CADH242N-GFP and CADH242A-GFP, defective of nuclease activity and
DNA-binding and nuclease activity, respectively, were constructed by over-
lapping PCR mutagenesis (Meiss et al., 2001). COOH- and NH2-terminal
truncations of CAD were obtained by PCR and then were subcloned into
pEGFP-N1 plasmid. The histone H1.1-GFP and the procaspase-3 vectors
were gifts from Dr. J. Th’ng (Northwestern Ontario Regional Cancer Cen-
ter, Thunder Bay, Ontario, Canada) and Dr. D. Andrews (McMaster Uni-
versity, Hamilton, Ontario, Canada), respectively. All constructs were veri-
fied by dideoxy chain termination DNA sequencing.
Cell culture, transfection, and induction of apoptosis
HeLa, COS-1, MCF7, and BHK-21 cells were grown in DME supple-
mented with 10% FBS at 37 C under an atmosphere of 5% CO2. MEFs
were isolated from ICAD knockout (ICAD
 / ) (Zhang et al., 1999). Trans-
fections were performed with FuGENE (Roche) and harvested after 24–48 h.
To limit the expression of CAD and to ensure that the exogenous ICAD
is complexed with CAD, the ratio of CAD/ICAD plasmid DNA was 2:1 in
transient transfections. Immunostaining of cells expressing HA-CAD/ICAD-
myc by the polyclonal anti-ICAD antibody indicated that ICAD-myc was
approximately fivefold overexpressed relative to the endogenous ICAD
level. In light of the obligatory heterodimerization of CAD, this implies that
CAD was not more than 4–5-fold overexpressed relative to its endogenous
level. ATP depletion was achieved by incubating the cells in glucose-free
medium with 4  g/ml anti-mycin, 10 mM deoxy-D-glucose, and 10  M
carbonyl cyanide p-chlorophenyl hydrazone at 37 C.
Immunocytochemistry
Cells were fixed in 4% PFA and HA, Myc, and ICAD were visualized
by indirect immunostaining as described previously (Lechardeur et al.,
2000). NuMA was detected with anti-NuMA mAb (Oncogene Research
Products) and histones with anti-histone mAb (Roche).
Apoptosis assays
Soluble DNA fragments were isolated according to the method described
by Cao et al. (2001) and visualized on agarose gel by ethidium bromide
staining. Phosphatidylserine translocation was monitored by incubating
the cells with AlexaFluor 568–conjugated annexin V (Molecular Probes,
Inc.), and activated caspase-3 was detected with the fluorescent red-
DEVD-fmk caspase-3 inhibitor (Oncogene Research Products) incubated
for 30 min preceding time-lapse imaging and FRAP analysis.
Immunoblotting and coimmunoprecipitation
Immunoblottings were performed on cells transiently transfected with the
indicated CAD and ICAD expression vectors (Lechardeur et al., 2000).
The CAD-GFP/ICAD was coimmunoprecipitated from the cell lysates using
a polyclonal anti-GFP antibody (Molecular Probes, Inc.) or monoclonal
anti-HA (Covance) and protein G–Sepharose. The Myc and HA epitopes
were detected with monoclonal anti-epitope (Covance) and HRP-conju-
gated secondary antibodies (Amersham Biosciences). CAD and ICAD
were immunoblotted with a rabbit anti-DFF40 (StressGen Biotechnologies)
and anti-ICAD (Lechardeur et al., 2000) antibodies, respectively.
Nuclear matrix isolation
Nuclear matrix from plated cells was prepared in cytoskeletal buffer (10
mM Pipes, 300 mM sucrose, 100 mM NaCl, 3 mM MgCl2, and 0.5% Tri-
ton X-100, pH 6.8) according to published protocol (Stenoien et al.,
2001). For immunostaining, the nuclear matrix preparation was fixed in
4% PFA. Immunoblotting was performed on isolated nuclear matrix solubi-
lized with RIPA buffer.
Confocal microscopy
Photobleaching experiments were performed on cells expressing the mini-
mum amount fluorescence permitting the measurements. For FRAP and FLIP
analysis, transfected cells were grown on 35-mm glass coverslips and kept
in a thermostated chamber (Molecular Probes, Inc.) in bicarbonate-free
 -MEM supplemented with 10 mM Hepes, pH 7.2, at 37 C during the
measurements. Microscopy was performed with an inverted laser confo-
cal fluorescence microscope (LSM 510; Carl Zeiss MicroImaging, Inc.)
equipped with a Plan-Apochromat 63 /NA 1.4 objective and the FITC
filter setting (488 nm/515 nm). A single x-y optical section was acquired
with a 6  zoom setting, and photobleaching was performed using the
488-nm line of an argon laser at 100% power. Images were acquired at
0.1% attenuated laser power. For quantitative FRAP experiments, the
bleach was performed using a 2- m width stripe across the nucleus with
1–2 iterations, enough to decrease the fluorescence of PFA-fixed cells to
the background fluorescence. Typically, the bleach time duration was
 200 ms. The 0 time point was defined as the mid-point of the bleach pe-
riod. For quantitative FRAP analysis, the average fluorescence intensity inNUCLEAR DYNAMICS OF CAD • LECHARDEUR ET AL. 861
the bleached area was measured using the LSM 510 software. The total
loss of fluorescence during the FRAP measurements was corrected by mon-
itoring the fluorescence outside the bleach area by setting the prebleach
intensity to 1 in the bleaching area, according to the equation: Ibl,corr(t)  
Ibl(t)/Icont(t))   (Icont( 0)/Ibl( 0)), where Ibl,corr(t) is the corrected intensity
value in the bleached area, Ibl(t) and Icont(t) are the raw intensities in the
bleached and background area, respectively, and Ibl( 0) and Icon( 0) are
the intensities in the same regions of the prebleach scan. The one-dimen-
sional diffusion coefficients were determined as the D value after fitting
the  corrected recovery curves according to the mathematical equation
Ibl,corr(t)   1   (w
2x(w
2   4 Dt)
 1)
1/2, where w is the width (2  m) of the
bleached stripe and t is the time. The time required for the recovery of half
the fluorescence was determined from the noncorrected intensity values
as the time corresponding to the intensity Ibl(t1/2)   Ibl(inf)/2 where Ibl(inf)
is the value of the intensity when the recovery is completed and assuming
that Ibl (0)   0.
For FLIP experiments, a 2- m-diam spot was bleached in every 10 s
for 20–30 iterations using similar settings as for FRAP, and the whole nu-
cleus was scanned after each pulse. Bleaching and image acquisition was
repeated until the fluorescence signal of the nucleus was decreased to the
background level. The ratio of the average fluorescence intensity of the half
nucleus opposite to the bleaching spot at each time point divided by its av-
erage intensity in the prebleach image was plotted versus time, and repre-
sents the rate of fluorescence decay during the FLIP experiment. Data were
analyzed with SigmaPlot and images were exported into Adobe Photoshop.
Online supplemental material
Fig. S1 shows FLIP in normal and apoptotic HeLa nuclei expressing CAD-
GFP. GFP-NLS remains mobile in apoptotic nuclei as demonstrated by
FRAP in Fig. S2. CAD-GFP immobilization is induced by UV or TNF  CHX
treatment of HeLa cells (Fig. S3). Point mutation of an amino acid residue
that is essential for DNA binding does not prevent CAD immobilization
(Fig. S4). Video 1 illustrates CAD-GFP diffusional mobility by FLIP in normal
and apoptotic HeLa and MCF7 cells. Online supplemental material avail-
able at http://www.jcb.org/cgi/content/full/jcb.200404105/DC1.
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